DIACCURATE
DIACCURATE ACQUIRES BIOKINESIS TO
CREATE A SOLE-IN-CLASS BIOTECH PLAYER
IN ONCOLOGY AND IMMUNOTHERAPY
Download Press Release
Home
Profile
Pipeline
News & Events
Contact Us
Plus